- Home
- PEGA vs BRKR Comparison
PEGA vs BRKR Comparison
Compare PEGA & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PEGA | BRKR |
|---|---|---|
| Founded | 1983 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.7B |
| IPO Year | 1996 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PEGA | BRKR |
|---|---|---|
| Price | $34.21 | $42.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $60.13 | $48.54 |
| AVG Volume (30 Days) | ★ 2.4M | 2.0M |
| Earning Date | 04-21-2026 | 05-06-2026 |
| Dividend Yield | 0.34% | ★ 0.58% |
| EPS Growth | ★ 91.89 | N/A |
| EPS | ★ 0.18 | 0.02 |
| Revenue | $682,695,000.00 | ★ $1,895,600,000.00 |
| Revenue This Year | $15.99 | $6.30 |
| Revenue Next Year | $11.90 | $3.81 |
| P/E Ratio | ★ $187.47 | $2,142.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.23 | $28.53 |
| 52 Week High | $105.50 | $56.22 |
Technical Indicators
Market Signals| Indicator | PEGA | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 37.64 | 59.10 |
| Support Level | N/A | $33.09 |
| Resistance Level | $44.95 | $49.44 |
| Average True Range (ATR) | 1.52 | 1.92 |
| MACD | -0.06 | 0.36 |
| Stochastic Oscillator | 34.45 | 77.94 |
Price Performance
Historical ComparisonAbout PEGA Pegasystems Inc.
Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.